Means Investment Company’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.67M | Buy |
4,726
+149
| +3% | +$152K | 0.43% | 35 |
|
|
2026
Q1 | $4.21M | Sell |
4,577
-89
| -2% | -$90.2K | 0.37% | 39 |
|
|
2025
Q4 | $5.01M | Sell |
4,666
-564
| -11% | -$539K | 0.42% | 36 |
|
|
2025
Q3 | $3.99M | Buy |
5,230
+209
| +4% | +$156K | 0.35% | 41 |
|
|
2025
Q2 | $3.91M | Buy |
5,021
+194
| +4% | +$151K | 0.37% | 41 |
|
|
2025
Q1 | $3.99M | Buy |
4,827
+1,606
| +50% | +$1.34M | 0.42% | 39 |
|
|
2024
Q4 | $2.49M | Buy |
3,221
+205
| +7% | +$170K | 0.26% | 53 |
|
|
2024
Q3 | $2.67M | Buy |
3,016
+43
| +1% | +$38.7K | 0.3% | 51 |
|
|
2024
Q2 | $2.69M | Sell |
2,973
-309
| -9% | -$247K | 0.32% | 47 |
|
|
2024
Q1 | $2.55M | Sell |
3,282
-3
| -0.1% | -$2.13K | 0.33% | 50 |
|
|
2023
Q4 | $1.91M | Sell |
3,285
-82
| -2% | -$47.9K | 0.28% | 60 |
|
|
2023
Q3 | $1.81M | Sell |
3,367
-240
| -7% | -$124K | 0.3% | 61 |
|
|
2023
Q2 | $1.69M | Buy |
3,607
+60
| +2% | +$25.2K | 0.27% | 66 |
|
|
2023
Q1 | $1.22M | Sell |
3,547
-213
| -6% | -$71.8K | 0.21% | 86 |
|
|
2022
Q4 | $1.38M | Buy |
3,760
+55
| +1% | +$19.5K | 0.28% | 74 |
|
|
2022
Q3 | $1.2M | Sell |
3,705
-30
| -0.8% | -$9.51K | 0.26% | 79 |
|
|
2022
Q2 | $1.21M | Buy |
3,735
+263
| +8% | +$78.9K | 0.26% | 79 |
|
|
2022
Q1 | $994K | Buy |
3,472
+47
| +1% | +$12.1K | 0.18% | 83 |
|
|
2021
Q4 | $946K | Buy |
3,425
+193
| +6% | +$48.9K | 0.17% | 86 |
|
|
2021
Q3 | $747K | Sell |
3,232
-25
| -0.8% | -$6.17K | 0.15% | 92 |
|
|
2021
Q2 | $748K | Buy |
3,257
+145
| +5% | +$29.1K | 0.15% | 90 |
|
|
2021
Q1 | $581K | Buy |
3,112
+44
| +1% | +$8.61K | 0.13% | 97 |
|
|
2020
Q4 | $622K | Buy |
3,068
+749
| +32% | +$112K | 0.14% | 90 |
|
|
2020
Q3 | $331K | Buy |
2,319
+13
| +0.6% | +$2.01K | 0.09% | 108 |
|
|
2020
Q2 | $347K | Sell |
2,306
-3
| -0.1% | -$460 | 0.11% | 100 |
|
|
2020
Q1 | $362K | Buy |
2,309
+2
| +0.1% | +$275 | 0.14% | 87 |
|
|
2019
Q4 | $322K | Buy |
2,307
+2
| +0.1% | +$232 | 0.11% | 112 |
|
|
2019
Q3 | $261K | Sell |
2,305
-398
| -15% | -$44.3K | 0.1% | 123 |
|
|
2019
Q2 | $306K | Buy |
2,703
+2
| +0.1% | +$236 | 0.13% | 116 |
|
|
2019
Q1 | $350K | Sell |
2,701
-231
| -8% | -$28.1K | 0.15% | 104 |
|
|
2018
Q4 | $339K | Buy |
+2,932
| New | +$328K | 0.19% | 94 |
|
Other funds holding LLY
Means Investment Company's LLY Position: Q2 2026 in Review
Means Investment Company increased its Eli Lilly (LLY) stake by 3.3% in Q2 2026, buying an estimated $152K and bringing the position to 4,726 shares worth $5.67M. The position accounts for 0.43% of the portfolio, ranked #35.
Means Investment Company first reported a position in LLY in Q4 2018 and has held it in 31 quarters since. 4,646 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Means Investment Company held 4,726 shares of Eli Lilly worth $5.67M as of Q2 2026.
- Means Investment Company bought 149 Eli Lilly shares in Q2 2026, an estimated $152K.
- Eli Lilly made up 0.43% of Means Investment Company's portfolio in Q2 2026, its #35 holding.
- Means Investment Company first reported a position in Eli Lilly in Q4 2018 and has held it in 31 quarters since.
- 4,646 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Means Investment Company's 13F filing for Q2 2026, filed 14 Aug 2026.